Moon Festival plan

This year could be the first year for me after I missed the Moon Festival almost 6 years. I leaved Cambodia to Vietnam since 2003 and from that year on, I never attended the Moon Festival in Cambodia at all.

This year, I just came back to my home-sweet-home again in the named of a Pharmacist and now i can enjoy the festival with all my relative and my friends.

Tomorrow morning (31/10/2009), one of my old friend is going to get married and i can’t miss this opportunity, i really want to see all my old friends and i want to share the happy with the bride and groom.

I will take some photos and i will share with you…

kekeke

Come Back With Touch!

Hi folks, I’ve been missing for long time, but yesterday i just came back with the perfect home internet connection which provided by a Vietnamese military company, Viettel. The speed is not fast enough but usable.

Oh, after i washed my old lady phone, Nokia 3230, that i have been used it for almost 4 years, i just bought a brand new HTC Touch Viva which i love the most (at this time) and after a week of using it, i felt very good and i really like it.

With Windows Mobile 6.1 professional, i can do anything that i want. i can do the office work, connectivities action, business and more. I love it and if anyone want to buy a new phone, please think about the Windows Mobile then. It’s really good, but, anyway, the speed is not fast enough if you guys compare to the iPhone.

Anyway, HI GUYS, I’M COME BACK!!

Offline at T&C Cofe

After about a month that we have graduated from Hanoi, finally we can join offline at T&C cafe together.

We’ve been very busy to find the job and busy with our job as well. The cafe in here is very different from any cafe in VN….I’ll tell you guys later about the differences between the cafe in VN and in Cambodia!.. hehe

New Find Explains Why Diabetes Drugs Affect the Heart

Softpedia website said:

Some time ago, researchers figured out that a specific class of anti-diabetes prescription drugs, known as thiazolidinediones (TZD), came with the risk of patients developing heart complications after use. The reason why this happened remained a mystery until recently, when a team of scientists managed to understand exactly how heart enlargement led to heart failure. The find, which was mostly the result of a study done on mice, may hold the clues experts need to prevent the side-effects of future generations of TZD. When the hearts increase, they switch from burning fat to burning glucose, which means that they have to get less oxygen, which saves energy. However, the latter fuel is not the optimum one, and the heart cells eventually become clogged with fat and commit suicide. The new study found that PPAR-γ was actually responsible for speeding up this transition. Further results of the study are available in the June issue of the scientific journal Cell Metabolism.

In a famous 2007 scandal, the drug Avandia (rosiglitazone), produced by GlaxoSmithKline, part of the TZD class, was proven to increase the chance of users taking it having a heart attack. While this set of pieces of evidence was highly controversial, another one holding that the compound was also associated with an increased frequency of heart failures was much less so. In heart failure, which is a fairly common condition, the heart becomes unable to pump sufficient blood through the body, which fails, Nature News reports.

“We already knew if you had heart failure you probably should not be taking these drugs, but this paper provides an additional explanation why,” Washington University School of Medicine (WUSM) Endocrinologist Clay Semenkovich said. According to the mouse study, the PPAR-γ, a TZD-activated molecule, is the main reason why heart failures appear. However, the investigation, which was led by Swiss Federal Institute of Technology Cancer Biologist Wilhelm Krek, was not focused on diabetes, but on studying what happened when the tissue of the heart enlarged, and how it affected the organ’s functions.

This could be a good news for all doctors, pharmacist and patients.